| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
Departments of
*
Ophthalmology,
Immunohematology and Blood Transfusion, and
Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
Ocular immune privilege is considered essential in the protection against sight-threatening immune responses, as illustrated by the ability of the ocular environment to permit the growth of tumors that are rejected when implanted at other sites. Although several studies indicate that soluble Ag can drain directly into the spleen when injected into the anterior chamber, the primary site of intraocular tumor Ag presentation to tumor-specific CTLs has not been studied. To gain a better understanding of the mechanism involved in ocular immune privilege, we examined to which lymphoid organs anterior chamber tumor Ags primarily drain. Our data show that intraocular tumor Ag drains exclusively to the submandibular lymph nodes, resulting in activation of tumor-specific CTLs, whereas no Ag drainage was found in spleen. However, these tumor-specific CTLs do not distribute systemically and, as a consequence, intraocular tumor growth is unhampered. A similar lack of CTL efficacy has been observed in mice bearing s.c. tumors, which is converted to a systemic tumoricidal CTL response by administration of agonistic anti-CD40 mAb. In contrast, systemic anti-CD40 treatment of eye tumor-bearing mice did not result in mobilizing tumor-specific CTLs or tumor eradication. Together, these results show that intraocular tumor Ag drains to regional lymph nodes for activation of tumor-specific CTLs. However, the induced tumor-specific immunity is insufficient for tumor clearance, even combined with otherwise highly effective immune intervention protocols.
This article has been cited by other articles:
|
|
 |
|
  J. L. Vega, H. Keino, and S. Masli Surgical Denervation of Ocular Sympathetic Afferents Decreases Local Transforming Growth Factor-{beta} and Abolishes Immune Privilege Am. J. Pathol., September 1, 2009; 175(3): 1218 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E Polak, N. J Borthwick, P. Johnson, J. L Hungerford, B. Higgins, S. Di Palma, M. J Jager, and I. A Cree Presence and phenotype of dendritic cells in uveal melanoma Br J Ophthalmol, July 1, 2007; 91(7): 971 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xu, M. Chen, D. M. Reid, and J. V. Forrester LYVE-1-Positive Macrophages Are Present in Normal Murine Eyes Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2162 - 2171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. McKenna and J. A. Kapp Accumulation of Immunosuppressive CD11b+ Myeloid Cells Correlates with the Failure to Prevent Tumor Growth in the Anterior Chamber of the Eye J. Immunol., August 1, 2006; 177(3): 1599 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. F. H. M. Boonman, L. R. H. M. Schurmans, N. van Rooijen, C. J. M. Melief, R. E. M. Toes, and M. J. Jager Macrophages are vital in spontaneous intraocular tumor eradication. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2959 - 2965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Camelo, J. Kezic, A. Shanley, P. Rigby, and P. G. McMenamin Antigen from the Anterior Chamber of the Eye Travels in a Soluble Form to Secondary Lymphoid Organs via Lymphatic and Vascular Routes. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1039 - 1046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. F. H. M. Boonman, G. J. D. van Mierlo, M. F. Fransen, R. J. W. de Keizer, M. J. Jager, C. J. M. Melief, and R. E. M. Toes Maintenance of Immune Tolerance Depends on Normal Tissue Homeostasis J. Immunol., October 1, 2005; 175(7): 4247 - 4254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Th. den Boer, G. J.D. van Mierlo, M. F. Fransen, C. J.M. Melief, R. Offringa, and R. E.M. Toes CD4+ T Cells Are Able to Promote Tumor Growth through Inhibition of Tumor-Specific CD8+ T-Cell Responses in Tumor-Bearing Hosts Cancer Res., August 1, 2005; 65(15): 6984 - 6989. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
